trimetazidine has been researched along with Cardiac Rupture, Post-Infarction in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gong, W; Li, A; Ma, Y; Nie, S; Shi, H | 1 |
1 other study(ies) available for trimetazidine and Cardiac Rupture, Post-Infarction
| Article | Year |
|---|---|
Trimetazidine suppresses oxidative stress, inhibits MMP-2 and MMP-9 expression, and prevents cardiac rupture in mice with myocardial infarction.
Topics: Animals; Antioxidants; Cell Line; Disease Models, Animal; Down-Regulation; Heart Rupture, Post-Infarction; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; Oxidative Stress; Rats; Trimetazidine; Ventricular Function, Left; Ventricular Remodeling | 2018 |